Intrinsic Value of S&P & Nasdaq Contact Us

iRhythm Technologies, Inc. IRTC NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
58/100
4/7 Pass
SharesGrow Intrinsic Value
$1,387.90
+1026.3%
Analyst Price Target
$210.91
+71.2%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

iRhythm Technologies, Inc. (IRTC) has a negative trailing P/E of -85.3, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 144.1 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -1.17%, forward earnings yield 0.69%. PEG 2.13.

Criteria proven by this page:

  • VALUE (100/100, Pass) — analyst target implies upside (+71.2%).
  • Forward P/E 144.1 — analysts expect a return to profitability with estimated EPS of $0.86 for FY2027.
  • PEG Ratio 2.13 — above 2.0 suggests expensive relative to earnings growth.
  • Trailing Earnings Yield -1.17% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 0.69% as earnings recover.
  • Analyst consensus target $210.91 (+71.2% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 58/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
58/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
94/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
MOAT
70/100
→ Income
GROWTH
100/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — IRTC

Valuation Multiples
P/E (TTM)-85.3
Forward P/E144.1
PEG Ratio2.13
Forward PEG2.13
P/B Ratio24.87
P/S Ratio5.09
EV/EBITDA-546.5
Per Share Data
EPS (TTM)$-1.38
Forward EPS (Est.)$0.86
Book Value / Share$4.74
Revenue / Share$23.16
FCF / Share$1.07
Yields & Fair Value
Earnings Yield-1.17%
Forward Earnings Yield0.69%
Dividend Yield0.00%
SharesGrow IV$1,387.90 (+1026.3%)
Analyst Target$210.91 (+71.2%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -7.6 -0.05 1.71 2.47 -
2017 -42.6 0.64 15.94 12.79 -
2018 -32.9 -0.59 30.49 11.27 -
2019 -31.5 -4.55 12.70 8.02 -
2020 -150.2 5.59 19.27 24.83 -
2021 -34.1 -0.29 12.35 10.69 -
2022 -24.1 -1.99 11.69 6.82 -
2023 -26.5 -6.42 15.55 6.63 -
2024 -24.8 2.45 30.94 4.75 -
2025 -127.5 2.07 37.18 7.60 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-3.95 $64.07M $-20.9M -32.6%
2017 $-1.30 $98.51M $-29.42M -29.9%
2018 $-2.02 $147.29M $-48.28M -32.8%
2019 $-2.16 $214.55M $-54.57M -25.4%
2020 $-1.58 $265.17M $-43.83M -16.5%
2021 $-3.46 $322.83M $-101.36M -31.4%
2022 $-3.88 $410.92M $-116.16M -28.3%
2023 $-4.04 $492.68M $-123.41M -25%
2024 $-3.63 $591.84M $-113.29M -19.1%
2025 $-1.39 $747.14M $-44.55M -6%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-0.30 $-1.09 – $0.56 $876.06M $875.65M – $876.34M 7
2027 $0.86 $0.36 – $1.23 $1.02B $995.66M – $1.05B 7
2028 $1.96 $1.60 – $2.33 $1.18B $1.18B – $1.18B 2
2029 $2.40 $2.37 – $2.45 $1.37B $1.36B – $1.4B 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message